Interestingly, most patients had mild or asymptomatic COVID-19 infection, whilst HUS presented with severe haemolytic anemia and acute kidney injury requiring transfusions, hemodialysis, and the C5 inhibitor eculizumab in 7 cases (56–59). The gene discussed is C5; the disease is hemolytic-uremic syndrome.